• 1. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 2. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Silanols

Introduction to CAS No. 39443-39-5 and SILICLAD

The compound with the CAS number 39443-39-5 is a specialized chemical entity that has garnered significant attention in the field of chemical and biomedical research. This compound, often referred to by the product name SILICLAD, has demonstrated remarkable potential in various applications, particularly in drug delivery systems and material science. The unique properties of this compound make it an attractive candidate for innovative research and development.

In recent years, the study of silica-based materials has seen substantial advancements, with compounds like CAS No. 39443-39-5 leading the way. Silica nanoparticles, including those derived from SILICLAD, have been extensively explored for their ability to enhance the efficacy of pharmaceutical formulations. These nanoparticles offer a high surface area-to-volume ratio, which is crucial for improving drug loading and release profiles. This characteristic has made them particularly useful in creating sustained-release formulations, thereby optimizing therapeutic outcomes.

The applications of SILICLAD extend beyond pharmaceuticals into the realm of biotechnology and environmental science. Researchers have leveraged its porous structure to develop efficient catalysts and adsorbents. The high surface area and tunable pore size of silica materials allow for precise control over reaction conditions, making them ideal for use in industrial processes and environmental remediation efforts. For instance, silica-based adsorbents have been employed to remove contaminants from water and air, showcasing the versatility of this compound.

One of the most compelling aspects of CAS No. 39443-39-5 is its biocompatibility, which has opened doors for its use in biomedical applications. Silica nanoparticles are known for their low toxicity and biodegradability, making them suitable for use in drug delivery systems, tissue engineering, and even as contrast agents in medical imaging. The ability to functionalize these nanoparticles further enhances their utility, allowing researchers to tailor their properties for specific applications. For example, surface modifications can be used to target nanoparticles to specific cells or tissues, thereby improving the precision of drug delivery.

The latest research on SILICLAD has highlighted its potential in nanomedicine. Studies have shown that silica nanoparticles can be engineered to carry multiple drugs simultaneously, a concept known as polymeric drug delivery systems. This approach has the potential to revolutionize cancer treatment by enabling targeted therapy that minimizes side effects while maximizing efficacy. The controlled release mechanisms afforded by silica nanoparticles ensure that drugs are released at a rate that maintains therapeutic levels in the body, reducing the need for frequent dosing.

In addition to its pharmaceutical applications, CAS No. 39443-39-5 has found utility in material science. The unique structural properties of silica materials make them ideal for use as reinforcing agents in composite materials. These materials exhibit enhanced mechanical strength and durability when silica nanoparticles are incorporated into their matrices. This has led to advancements in industries ranging from aerospace to automotive, where lightweight yet strong materials are highly valued.

The environmental benefits of using silica-based materials are also noteworthy. Silica is abundant and renewable, making it an eco-friendly alternative to traditional materials like plastics. Furthermore, its ability to adsorb harmful substances makes it an effective tool for pollution control. For instance, silica-based filters have been used to purify industrial wastewater, reducing the environmental impact of manufacturing processes.

The future prospects of SILICLAD are promising, with ongoing research exploring new ways to harness its potential. Innovations in nanotechnology continue to push the boundaries of what is possible with silica-based materials, opening up new avenues for application in medicine, industry, and environmental science. As our understanding of these materials grows, so too does their potential to address some of the most pressing challenges facing society today.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)